Skip to content

The effect of fixed-ratio ciprofol and remifentanil effect-site target-controlled infusion maintenance anesthesia on postoperative neurocognitive recovery in elderly patients: A randomized controlled exploratory study

The effect of fixed-ratio ciprofol and remifentanil effect-site target-controlled infusion maintenance anesthesia on postoperative neurocognitive recovery in elderly patients: A randomized controlled exploratory study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600125525
Enrollment
Unknown
Registered
2026-05-27
Start date
2026-06-01
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Early postoperative neuro-cognitive disorders (PND)

Interventions

Light Anesthesia Group:ciprofol and remifentanil infused at a fixed ratio to maintain a relatively light anesthesia
Deep Anesthesia Group:ciprofol and remifentanil infused at a fixed ratio to maintain a relatively deep anesthesia

Sponsors

Peking University First Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
65 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Aged >=65 years; 2.Planned to undergo non-cardiac surgery under general anesthesia with an expected surgery duration >=1 hour; 3.Requiring patient-controlled intravenous analgesia (PCIA) postoperatively; 4.Signed informed consent form;

Exclusion criteria

Exclusion criteria: 1. Unable to communicate before the operation due to visual, auditory, language impairments or severe dementia; 2. Preoperative conditions such as schizophrenia, epilepsy, Parkinson's disease, and myasthenia gravis; 3. Craniocerebral injury or neurosurgery; 4. Severe abnormal liver function (Child-Pugh grade C); 5. Severe renal dysfunction (eGFR = grade IV; 7. It is expected that the patient will be admitted to the ICU with a tube after the operation; 8. Participate in other clinical studies; 9. Situations where other researchers or attending physicians consider it inappropriate to participate in the study.

Design outcomes

Primary

MeasureTime frame
Incidence of postoperative day 3/discharge dNCR;

Secondary

MeasureTime frame
Incidence of postoperative delirium within 4 days/discharge;Incidence of postoperative day 30 pNCD;

Countries

China

Contacts

Public ContactSong Linlin

Peking University First Hospital

1131_1131@163.com+86 10 83575138

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jun 11, 2026